Legal & General Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,821
| Closed | -$471K | – | 3762 |
|
|
2022
Q1 | $471K | Buy |
16,821
+1,350
| +9% | +$37K | ﹤0.01% | 2410 |
|
|
2021
Q4 | $423K | Buy |
15,471
+23
| +0.1% | +$623 | ﹤0.01% | 2465 |
|
|
2021
Q3 | $420K | Buy |
15,448
+5,990
| +63% | +$148K | ﹤0.01% | 2471 |
|
|
2021
Q2 | $162K | Sell |
9,458
-635
| -6% | -$11.9K | ﹤0.01% | 2593 |
|
|
2021
Q1 | $210K | Buy |
10,093
+1,457
| +17% | +$33.6K | ﹤0.01% | 2448 |
|
|
2020
Q4 | $198K | Sell |
8,636
-1,555
| -15% | -$29.6K | ﹤0.01% | 2423 |
|
|
2020
Q3 | $167K | Sell |
10,191
-1,318
| -11% | -$23.9K | ﹤0.01% | 2388 |
|
|
2020
Q2 | $155K | Buy |
11,509
+478
| +4% | +$5.56K | ﹤0.01% | 2415 |
|
|
2020
Q1 | $131K | Sell |
11,031
-259
| -2% | -$5.74K | ﹤0.01% | 2346 |
|
|
2019
Q4 | $281K | Buy |
11,290
+1,208
| +12% | +$24.5K | ﹤0.01% | 2326 |
|
|
2019
Q3 | $171K | Buy |
10,082
+4,200
| +71% | +$76.4K | ﹤0.01% | 2382 |
|
|
2019
Q2 | $134K | Buy |
5,882
+355
| +6% | +$9.57K | ﹤0.01% | 2447 |
|
|
2019
Q1 | $178K | Buy |
5,527
+174
| +3% | +$5.38K | ﹤0.01% | 2350 |
|
|
2018
Q4 | $151K | Buy |
5,353
+690
| +15% | +$20.2K | ﹤0.01% | 2370 |
|
|
2018
Q3 | $134K | Hold |
4,663
| – | – | ﹤0.01% | 2428 |
|
|
2018
Q2 | $175K | Sell |
4,663
-392
| -8% | -$15.4K | ﹤0.01% | 2329 |
|
|
2018
Q1 | $199K | Sell |
5,055
-2,017
| -29% | -$73.7K | ﹤0.01% | 2296 |
|
|
2017
Q4 | $230K | Buy |
7,072
+280
| +4% | +$8.4K | ﹤0.01% | 2270 |
|
|
2017
Q3 | $208K | Sell |
6,792
-147
| -2% | -$4.35K | ﹤0.01% | 2334 |
|
|
2017
Q2 | $193K | Buy |
6,939
+255
| +4% | +$5.77K | ﹤0.01% | 2311 |
|
|
2017
Q1 | $116K | Sell |
6,684
-84
| -1% | -$1.18K | ﹤0.01% | 2467 |
|
|
2016
Q4 | $81K | Buy |
6,768
+3,965
| +141% | +$51.3K | ﹤0.01% | 2691 |
|
|
2016
Q3 | $44K | Hold |
2,803
| – | – | ﹤0.01% | 2587 |
|
|
2016
Q2 | $36K | Buy |
+2,803
| New | +$43.9K | ﹤0.01% | 2645 |
|
Legal & General Group's XENT Position: Q2 2022 in Review
Legal & General Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 16,821 shares — an estimated $471K sold.
Legal & General Group first reported a position in XENT in Q2 2016 and held it in 24 quarters. The position peaked at $471K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Legal & General Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Legal & General Group sold 16,821 Intersect ENT, Inc shares in Q2 2022, an estimated $471K.
- Legal & General Group first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 24 quarters.
- Legal & General Group's Intersect ENT, Inc position peaked at $471K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.